REFERENCES

1. Dellborg M. Adult congenital heart disease. Circulation. 2024;149:1397-9.

2. McElhinney DB, Hennesen JT. The Melody® valve and Ensemble® delivery system for transcatheter pulmonary valve replacement. Ann N Y Acad Sci. 2013;1291:77-85.

3. Mongeon FP, Ben Ali W, Khairy P, et al. Pulmonary valve replacement for pulmonary regurgitation in adults with tetralogy of fallot: a meta-analysis-a report for the writing committee of the 2019 update of The Canadian Cardiovascular Society Guidelines For The Management Of Adults With Congenital Heart Disease. Can J Cardiol. 2019;35:1772-83.

4. Demonceaux M, Benseba J, Ruiz M, et al. Right ventricular remodeling in complex congenital heart disease. Can J Cardiol. 2025;41:1067-80.

5. Soulat G, Alattar Y, Ladouceur M, et al. Discordance between 2D and 4D flow in the assessment of pulmonary regurgitation severity: a right ventricular remodeling follow-up study. Eur Radiol. 2023;33:5455-64.

6. Cools B, Nagaraju CK, Vandendriessche K, et al. Reversal of right ventricular remodeling after correction of pulmonary regurgitation in tetralogy of fallot. JACC Basic Transl Sci. 2023;8:301-15.

7. Georgiev S, Ewert P, Eicken A, et al. Munich comparative study: prospective long-term outcome of the transcatheter melody valve versus surgical pulmonary bioprosthesis with up to 12 years of follow-up. Circ Cardiovasc Interv. 2020;13:e008963.

8. Liang R, Abudurexiti N, Wu J, et al. Exosomes and miRNAs in cardiovascular diseases and transcatheter pulmonary valve replacement: advancements, gaps and perspectives. Int J Mol Sci. 2024;25:13686.

9. Matsumoto S, Sakata Y, Suna S, et al. Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ Res. 2013;113:322-6.

10. Sinning JM, Losch J, Walenta K, Böhm M, Nickenig G, Werner N. Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J. 2011;32:2034-41.

11. Hosseinkhani B, Kuypers S, van den Akker NMS, Molin DGM, Michiels L. Extracellular vesicles work as a functional inflammatory mediator between vascular endothelial cells and immune cells. Front Immunol. 2018;9:1789.

12. Cappucci IP, Tremoli E, Zavan B, Ferroni L. Circulating extracellular vesicles in cardiovascular disease. Int J Mol Sci. 2025;26:6817.

13. Wu D, Yan J, Shen X, et al. Profiling surface proteins on individual exosomes using a proximity barcoding assay. Nat Commun. 2019;10:3854.

14. Welsh JA, Arkesteijn GJA, Bremer M, et al. A compendium of single extracellular vesicle flow cytometry. J Extracell Vesicles. 2023;12:e12299.

15. Van Gassen S, Callebaut B, Van Helden MJ, et al. FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data. Cytometry A. 2015;87:636-45.

16. Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.

17. Cieslak MC, Castelfranco AM, Roncalli V, Lenz PH, Hartline DK. t-Distributed Stochastic Neighbor Embedding (t-SNE): a tool for eco-physiological transcriptomic analysis. Mar Genomics. 2020;51:100723.

18. Roca CP, Burton OT, Neumann J, et al. A cross entropy test allows quantitative statistical comparison of t-SNE and UMAP representations. Cell Rep Methods. 2023;3:100390.

19. Andrews LP, Marciscano AE, Drake CG, Vignali DA. LAG3 (CD223) as a cancer immunotherapy target. Immunol Rev. 2017;276:80-96.

20. Mulholland M, Kritikou E, Katra P, et al. LAG3 regulates T cell activation and plaque infiltration in atherosclerotic mice. JACC CardioOncol. 2022;4:635-45.

21. Kim TT, Dyck JR. The role of CD36 in the regulation of myocardial lipid metabolism. Biochim Biophys Acta. 2016;1861:1450-60.

22. Bartoli-Leonard F, Harris AG, Saunders K, et al. Altered inflammatory state and mitochondrial function identified by transcriptomics in paediatric congenital heart patients prior to surgical repair. Int J Mol Sci. 2024;25:7487.

23. Ueland T, Åkerblom A, Ghukasyan T, et al. ; PLATO Investigators. ALCAM predicts future cardiovascular death in acute coronary syndromes: insights from the PLATO trial. Atherosclerosis. 2020;293:35-41.

24. Delgado C, Bu L, Zhang J, et al. Neural cell adhesion molecule is required for ventricular conduction system development. Development. 2021;148:dev199431.

25. Jha R, Singh M, Wu Q, Gentillon C, Preininger MK, Xu C. Downregulation of LGR5 expression inhibits cardiomyocyte differentiation and potentiates endothelial differentiation from human pluripotent stem cells. Stem Cell Reports. 2017;9:513-27.

26. Huang S, Kang Y, Liu T, Xiong Y, Yang Z, Zhang Q. The role of immune checkpoints PD-1 and CTLA-4 in cardiovascular complications leading to heart failure. Front Immunol. 2025;16:1561968.

27. Qin W, Cao L, Massey IY. Role of PI3K/Akt signaling pathway in cardiac fibrosis. Mol Cell Biochem. 2021;476:4045-59.

28. Gul B, Syed F, Khan S, Iqbal A, Ahmad I. Characterization of extracellular vesicles by flow cytometry: challenges and promises. Micron. 2022;161:103341.

29. Poudel S, Nelson DL, Yen JH, et al. Intermethod characterization of commercially available extracellular vesicles as reference materials. Biomolecules. 2025;16:66.

30. Jin X, Xu W, Wu Q, Huang C, Song Y, Lian J. Detecting early-warning biomarkers associated with heart-exosome genetic-signature for acute myocardial infarction: a source-tracking study of exosome. J Cell Mol Med. 2024;28:e18334.

31. Szebényi K, Péntek A, Erdei Z, et al. Efficient generation of human embryonic stem cell-derived cardiac progenitors based on tissue-specific enhanced green fluorescence protein expression. Tissue Eng Part C Methods. 2015;21:35-45.

Extracellular Vesicles and Circulating Nucleic Acids
ISSN 2767-6641 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/